Oxford Sciences Innovation (OSI) is the world’s largest university-partnered venture firm, working with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems.
Founded in 2015, OSI has worked with over 200 of Oxford’s leading academics to build a portfolio of more than 100 companies worth over $2 billion.
OSI’s portfolio of companies spans four sectors, Life Sciences, Deep Tech, Health Tech and Software & AI, tackling challenges like the diagnosis and treatment of devastating rare diseases and cancer, sustainability, nuclear fusion, quantum computing and cyber-security.
These companies, based on Oxford science, have created over 1,500 new jobs and added 55,000 square feet of laboratory and startup space to Oxford’s renowned research and science ecosystem. A place where scientific breakthroughs become world-changing businesses.
The companies include Vaccitech that co-invented the Oxford Vaccine, Base Genomics that created early-stage cancer detection technology, and First Light Fusion that makes clean, virtually limitless energy a reality.
The University of Oxford is home to some of the world’s most creative and innovative scientific thinkers and leaders and is ranked #1 in the world for scientific research.
OSI’s unique partnership grants them unrivalled access to Oxford’s academics, research and IP within the Medical Sciences and Mathematics, Physical and Life Sciences Divisions. They identify cutting-edge research, scientific breakthroughs and advances in technology capable of changing the world and turn these game-changing ideas into credible businesses.